10-Feb-2026
Dentsply Sirona to Host Fourth Quarter and Full Year Conference Call on February 26
Globe Newswire (Thu, 5-Feb 4:15 PM ET)
PRNewswire (Mon, 26-Jan 8:15 AM ET)
Shareholder Action Alert at Dentsply Sirona (XRAY): Why Investors Are Being Urged to Act Now
Market Chameleon (Fri, 16-Jan 6:38 AM ET)
Business Wire (Thu, 15-Jan 11:43 AM ET)
Patterson Dental and Dentsply Sirona Renew U.S. Dental Technology Distribution Partnership
Globe Newswire (Wed, 14-Jan 8:00 AM ET)
Globe Newswire (Tue, 13-Jan 4:30 PM ET)
Dentsply Sirona Appoints Donald Zurbay to Board of Directors
Globe Newswire (Tue, 13-Jan 8:00 AM ET)
Globe Newswire (Mon, 12-Jan 9:00 AM ET)
Dentsply Sirona to Present at the 44th Annual J.P. Morgan Healthcare Conference
Globe Newswire (Tue, 6-Jan 4:15 PM ET)
Dentsply Sirona Declares Quarterly Cash Dividend
Globe Newswire (Mon, 15-Dec 8:00 AM ET)
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
Dentsply Sirona trades on the NASDAQ stock market under the symbol XRAY.
As of February 10, 2026, XRAY stock price climbed to $13.93 with 4,342,639 million shares trading.
XRAY has a beta of 1.12, meaning it tends to be more sensitive to market movements. XRAY has a correlation of 0.19 to the broad based SPY ETF.
XRAY has a market cap of $2.77 billion. This is considered a Mid Cap stock.
Last quarter Dentsply Sirona reported $904 million in Revenue and $.37 earnings per share. This beat revenue expectation by $5 million and missed earnings estimates by -$.08.
In the last 3 years, XRAY traded as high as $43.24 and as low as $9.85.
The top ETF exchange traded funds that XRAY belongs to (by Net Assets): IJH, VTI, VB, VBR, VXF.
XRAY has underperformed the market in the last year with a return of -22.3%, while SPY returned +16.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in XRAY shares. However, XRAY has outperformed the market in the last 3 month and 2 week periods, returning +26.0% and +9.5%, while SPY returned +3.4% and -0.1%, respectively. This indicates XRAY has been having a stronger performance recently.
XRAY support price is $13.32 and resistance is $14.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XRAY shares will trade within this expected range on the day.